Učitavanje...
What do oncologists need to know about biosimilar products?
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of...
Spremljeno u:
| Izdano u: | Chin J Cancer |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062853/ https://ncbi.nlm.nih.gov/pubmed/27733189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0151-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|